跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
pyrimidinedione
首页
药物
pyrimidinedione
pyrimidinedione
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FATTY LIVER DISEASE TREATMENT USING GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR ANTAGONISTS
EP 3206692 B1
申请人: CORCEPT THERAPEUTICS INC
优先权: 2014
CN
EP
US
WO
15 件公开
PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS
EP 3010910 A1
申请人: MYOKARDIA INC
优先权: 2013
EP
US
WO
15 件公开
TETRAHYDROPYRAN (THP)-SUBSTITUTED BICYCLIC-PYRIMIDINEDIONE COMPOUNDS
EP 3873904 B1
申请人: MYOKARDIA INC
优先权: 2018
CN
EP
US
WO
13 件公开
Pyrimidine cyclohexyl glucocorticoid receptor modulators
US 8685973 B2
申请人: CLARK ROBIN
优先权: 2012
US
6 件公开
TREATMENT OF HCM WITH PYRIMIDINEDIONE COMPOUNDS
US 2020054636 A1
申请人: MYOKARDIA INC
优先权: 2019
US
6 件公开
PYRIMIDINEDIONE-BASED COMPOUNDS AS AXL, C-MET, AND MER INHIBITORS AND METHODS OF USE THEREOF
EP 4479397 A4
申请人: CMG PHARMACEUTICAL CO LTD
优先权: 2022
CN
EP
US
4 件公开
Formulations of pyrimidinedione derivative compounds
US 9629841 B2
申请人: ABBVIE INC
优先权: 2012
CN
US
4 件公开
Pyrimidinedione derivatives
US 7101873 B2
申请人: BEXEL PHARMACEUTICALS INC
优先权: 2002
US
4 件公开
US 2009137457 A1
申请人: CONCERT PHARMACEUTICALS INC
优先权: 2008
US
Use of pyrimidinedione derivative for preventing or treating hepatitis C
US 7851479 B2
申请人: SAMJIN PHARM CO LTD
优先权: 2006
CN
US
3 件公开
Therapeutic agent for inflammatory bowel disease
US 7820686 B2
申请人: TAIHO PHARMACEUTICAL CO LTD
优先权: 2006
CN
US
3 件公开
第 1 / 7 页
上一页
下一页
药物
反馈